Improved efficacy with nonsimultaneous administration of netilmicin and minocycline against methicillin-resistant Staphylococcus aureus in in vitro and in vivo models

International Journal of Antimicrobial Agents

Volumn 11, Issue 1, 1999, Pages 39-46

  Goto, Yoichiro ^a   Hiramatsu, Kazufumi ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Combination therapy; Methicillin resistant; Minocycline; Netilmicin; Staphylococcus aureus

Indexed keywords

MINOCYCLINE; NETILMICIN;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; COMPUTER SIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SENSITIVITY; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; DRUG ADMINISTRATION SCHEDULE; FEMALE; METHICILLIN RESISTANCE; MICE; MICE, INBRED ICR; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MODELS, BIOLOGICAL; NETILMICIN; STAPHYLOCOCCUS AUREUS;

EID: 0032927052     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(98)00081-8     Document Type: Article

References (24)

1. Jevon M.P. Celebin-resistant Staphylococci. Br. Med. J. 1:1961;124-125.
2. Shanson DC, Kensit JG, DukeR. Outbreak of hospital infection with a strain of Staphylococcus aureus resistant to gentamicin and methicillin. 1976;ii:1347-48.
3. Myers J.P., Linnemann C.C. Bacteremia due to methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 145:1982;532-536.
4. Panlilio A.L., Culver D.H., Gaynes R.P. et al. Methicillin-resistant Staphylococcus aureus in US hospitals 1975-1981. Infect. Cont. Hosp. Epidemiol. 13:1992;582-586.
5. Voss A., Milatovic D., Wallrauch-Schwarz C., Rosdahl V.T., Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 13:1994;50-55.
6. Milatovic D. Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives? Eur. J. Microbiol. 5:1986;689-692.
7. Sorrell T.C., Collingnon P.J. A prospective study of adverse reactions associated with vancomycin therapy. J. Antimicrob. Chemother. 16:1985;235-241.
8. Rahman M. Alternatives to vancomycin in treating methicillin-resistant Staphylococcus aureus infections. J. Antimicrob. Chemother. 41:1998;325-328.
9. Brink A.J., Huygens F., Van Rensburg A.J. Alternative antimicrobial options against multiply resistant Staphylococcus aureus. J. Antimicrob. Chemother. 31:1993;180-182.
10. Oka S., Goto M., Kaji Y. et al. Synergic activity of imipenem/cilastatin combined with cefotiam against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 31:1993;533-541.
11. Barclay M.L., Begg E.J., Chamber S.T., Boswell D.R. Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro. Antimicrob. Agents Chemother. 39:1995;132-136.
12. Chavanet P., Muggeo E., Waldner A., Dijoux S., Caillot D., Portier H. Synergism between cefotaxime and fosfomycin in the therapy of methicillin and gentamicin resistant Staphylococcus aureus infection in rabbits. Eur. J. Clin. Microbiol. Infect. Dis. 9:1990;271-275.
13. McGrath B.J., Kang S.L., Kaatz G.W., Rybak M.J. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylcoccus aureus in an in vitro pharmacodynamic model of endocarditis. Antimicrob. Agents Chemother. 38:1994;2034-2040.
14. Kang S.L., Rybak M.J., McGrath B.J., Kaatz G.W., Seo S.M. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and-resistant Staphylococcus aureus in an in vitro infection model. Antimicrob. Agents Chemother. 38:1994;2702-2709.
15. Hasegawa H. Combination therapy of fosfomycin and flomoxef in methicillin-resistant Staphylococcus aureus infections: an in vitro experimental study on order and dose. Chemother. (Tokyo). 39:1991;771-781.
16. Tokue Y., Shoji S., Satoh K., Watanabe A., Motomiya M. Comparison of a polymerase chain reaction assay and conventional microbiologic method for detection of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 36:1992;6-9.
17. Song M.D., Wachi M., Doi M., Ishino F., Matsuhashi M. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Letts. 221:1987;167-171.
18. Eliopoulos GM, Moellering RC. Antibiotic combinations. In: Lorian V, editor. Antibiotics in laboratory medicine, 3rd ed. Baltimore: Williams and Wilkins, 1991:432-92.
19. Sonoda T., Nishimura K., Imamura N. et al. In-vitro killing effect of antibiotics. Clin. Rep. 18:1984;4405-4414.
20. Saito A., Kato Y., Ishikawa K. et al. A basic study on netilmicin. Chemother. (Tokyo). 29 Suppl 3:1981;S71-S82.
21. Ishigami J., Mita T., Tanikaze S. et al. Application of minocycline for intravenous drip in urological field. Jpn. J. Antibiot. 27:1974;307-314.
22. Cash H.A., Woods D.E., McCullough B., Johanson W.G., Bass J.A. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 119:1979;453-459.
23. Gilbert DN. Aminoglycosides. In: Mandell GL, Douglas RG Jr, Bennett JE, editors. Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingstone, 1995:279-306.
24. Craig WA, Gudmundsson S. Postantibiotic effect. In: Lorian V, editor. Antibiotics in laboratory medicine, 3rd ed. Baltimore: Williams and Wilkins, 1991:403-31.